Summary
In five large-scale prospective studies the predictive value of hemostatic parameters indicating the occurrence of arterial thrombotic diseases has been estimated in healthy individuals. All the studies have consistently found a statistically significant association between hyperfibrinogenemia and arterial thrombotic diseases. In two studies, increased levels of factor VII were associated with an increased incidence of ischemic heart disease. The relationship between arterial occlusive diseases and plasma levels of fibrinogen or factor VII was closer than that for other well established risk factors such as plasma cholesterol. These data indicate the important pathogenetic role carried out by alterations of the clotting system in occlusive arterial diseases.
This is a preview of subscription content, log in via an institution to check access.
References
Balleisen L., Bailey J., Epping P.-H., Schulte H., Van De Loo J.: Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to the age, gender, body weight, smoking, alcohol, pill using and menopause — Thrombos. Haemost.54, 475, 1985.
Balleisen L., Schulte H., Assmann G., Epping P.-H., van de Loo J.: Coagulation factors and the progress of coronary heart disease — Lancetii, 461, 1987.
Doll R., Peto R.: Mortality in relation to smoking: 20 years’ observation on male British doctors — Brit. med. J.ii, 1525, 1976.
Gurewich V., Lipinski B., Hyde E.: The effect of the fibrinogen concentration and the leukocyte count on intravascular fibrin deposition from soluble fibrin monomer complexes — Thrombos. Haemost.36, 605, 1976.
Humphries S. E., Cook M., Dubowitz M., Stirling Y., Meade T. W.: Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentration — Lanceti, 1452, 1987.
Kannel W. B., Wolf P. A., Castelli W. P., D’Agostino R. B.: Fibrinogen and risk of cardiovascular disease. The Framingham Study — J. Amer. med. Ass.258, 1183, 1987.
Lowe G. D. O.: Blood rheology in arterial disease — Clin. Sci.68, 419, 1985.
Meade T. W.: Clotting factors and ischemic heart disease: the epidemiological evidence. In:Meade T. W. (Ed.): Anticoagulants and myocardial infarction. J. Wiley, Chichester, 1984; p. 91.
Meade T. W., Chakrabarti R. R., Haines A. P., North W. R. S., Stirling Y.: Haemostatic, lipid and blood pressure profiles of women and oral contraceptives containing 30 or 50 μg oestrogens — Lancetii, 948, 1977.
Meade T. W., Greenberg G., Thompson S. G.: Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations — Brit. med. J.i, 157, 1980.
Meade T. W., Mellows S., Brozovic M., Miller S. G., Chakrabarti R. R., North W. R. S., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G.: Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study — Lancetii, 533, 1986.
Meade T. W., North W. R. S., Chakrabarti R. R., Stirling Y., Haines A. P., Thompson S. G.: Haemostatic function and cardiovascular death: early results of a prospective study — Lanceti, 1050, 1980.
Meade T. W., Stirling Y., Thompson S. G., Ajdukiewicz A. B., Barbara J. A. J., Chalmers D. M.: Carriers of hepatitis B surface antigen: possible association between low levels of clotting factors and protection against ischemic heart disease — Thrombos. Res.45, 709, 1987.
Meade T. W., Stirling Y., Thompson S. G., Vickers M. V., Woolf L., Ajdukiewicz A. B., Stewart G., Davidson J. F., Walker I. D., Douglas A. S., Richardson I. M., Weir R. D., Aromaa A., Impivaara O., Maatela J., Hladovec J.: An international and interregional comparison of hemostatic variables in the study of ischaemic heart disease — Int. J. Epidemiol.15, 331, 1986.
Meade T. W., Vickers M. V., Thompson S. G., Seghatchian M. J.: The effect of physiological level of fibrinogen on platelet aggregation — Thrombos. Res.38, 527, 1985.
Meade T. W., Vickers M. V., Thompson S. G., Stirling Y., Haines A. P., Miller G. J.: Epidemiological characteristics of platelet aggregability — Brit. med.J.290, 428, 1985.
Miller G. I., Martin J. C., Webster J., Wilkes H., Miller N. E., Wilkinson W. H., Meade T. W.: Association between dietary fat intake and plasma factor VII coagulant activity — a predictor of cardiovascular mortality — Atherosclerosis60, 269, 1986.
Nemerson Y., Zur M., Bach R., Gentry R.: The mechanism of action of tissue factor. In:Mann K. G., Taylor F. P. (Eds): Regulation of coagulation. Vol. 8: Developments in biochemistry. Elsevier/North-Holland, Amsterdam, 1980; p. 193.
Smith E. B.: Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis — Clin. Haematol.15, 355, 1986.
Stone M. C., Thorpe J. M.: Plasma fibrinogen — a major coronary risk factor — J. roy. Coll. gen. Practit.35, 565, 1985.
Welin L., Svardsudd K., Wilhelmsen L., Larsson B., Tibblin G.: Analysis of risk factors for stroke in a cohort of men born in 1913 — New Engl. J. Med.317, 522, 1987.
Wilhelmsen L., Svardsudd K., Korsan-Bengtssen K., Larsson B., Welin L., Tibblin G.: Fibrinogen as a risk for stroke and myocardial infarction — New Engl. J. Med.311, 501, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cattaneo, M., Mannucci, P.M. Predictive value of coagulation tests in arterial thrombosis. La Ricerca Clin. Lab. 18, 1–7 (1988). https://doi.org/10.1007/BF02918813
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02918813